A Texas Alzheimer's patient has seen significant improvement after starting an experimental medication. Gail Youngdale was living with progressive Alzheimer's disease when she began taking lecanemab, also known as Leqembi. Her daughter, Teri Youngdale, reports that scans no longer show amyloid plaque in her brain, which was previously present in nine different spots.

Gail Youngdale's story is part of a national campaign to advance Alzheimer's research. She has also experienced a renewed sense of independence and recently got married. Further details about her story and the national campaign are available.